Becker’s Hospital Review
Boris Pasche, M.D., Ph.D., FACP, president and CEO at Karmanos, answered some questions about the new FDA-approved TheraBionic P1 device, an at-home treatment for advanced liver cancer patients. Dr. Pasche is also the co-inventor of the device. He explained how the device works and how physicians can monitor how much treatment the patient is receiving.
Read the article here.